Next Article in Journal
Inhibition of SARS-CoV-2-Induced NLRP3 Inflammasome-Mediated Lung Cell Inflammation by Triphala-Loaded Nanoparticle Targeting Spike Glycoprotein S1
Previous Article in Journal
Impact of Time on Parameters for Assessing the Microstructure Equivalence of Topical Products: Diclofenac 1% Emulsion as a Case Study
Previous Article in Special Issue
Photodynamic Therapy, Probiotics, Acetic Acid, and Essential Oil in the Treatment of Chronic Wounds Infected with Pseudomonas aeruginosa
 
 
Review

Article Versions Notes

Pharmaceutics 2024, 16(6), 750; https://doi.org/10.3390/pharmaceutics16060750
Action Date Notes Link
article html file updated 12 September 2025 22:00 CEST Update https://www.mdpi.com/1999-4923/16/6/750/html
article html file updated 24 August 2025 22:06 CEST Update -
article html file updated 26 June 2025 03:07 CEST Update -
article html file updated 26 June 2024 05:48 CEST Original file -
article pdf uploaded. 26 June 2024 05:47 CEST Updated version of record https://www.mdpi.com/1999-4923/16/6/750/pdf
article xml uploaded. 26 June 2024 05:47 CEST Update https://www.mdpi.com/1999-4923/16/6/750/xml
article xml file uploaded 26 June 2024 05:47 CEST Original file -
article pdf uploaded. 2 June 2024 11:26 CEST Version of Record https://www.mdpi.com/1999-4923/16/6/750/pdf-vor
Back to TopTop